Activated Ras Signals Developmental Progression of  Recombinase-activating Gene (RAG)-deficient Pro-B  Lymphocytes by Shaw, Albert C. et al.
 
123
 
J. Exp. Med. © The Rockefeller University Press • 0022-1007/99/01/123/07 $2.00
Volume 189, Number 1, January 4, 1999 123–129
http://www.jem.org
 
Activated Ras Signals Developmental Progression of 
Recombinase-activating Gene (RAG)-deﬁcient Pro-B 
Lymphocytes
 
By Albert C. Shaw,
 
*
 
‡
 
i
 
¶
 
 Wojciech Swat,
 
§‡
 
i
 
 Roger Ferrini,
 
‡
 
 
Laurie Davidson,
 
*
 
‡
 
 and Frederick W. Alt
 
*
 
‡§
 
i
 
From the 
 
*
 
Howard Hughes Medical Institute, Boston, Massachusetts 02115; 
 
‡
 
The Children’s 
Hospital, Boston, Massachusetts 02115; the 
 
§
 
Center for Blood Research and the 
 
i
 
Department of 
Genetics, Harvard Medical School, Boston, Massachusetts 02115; and the 
 
¶
 
Infectious Disease Unit, 
Massachusetts General Hospital, Boston, Massachusetts 02114
 
Summary
 
To elucidate the intracellular pathways that mediate early B cell development, we directed ex-
pression of activated Ras to the B cell lineage in the context of the recombination-activating
gene 1 (RAG1)-deficient background (referred to as Ras–RAG). Similar to the effects of an
immunoglobulin (Ig) 
 
m
 
 heavy chain (HC) transgene, activated Ras caused progression of
RAG1–deficient progenitor (pro)-B cells to cells that shared many characteristics with precur-
sor (pre)-B cells, including downregulation of surface CD43 expression plus expression of 
 
l
 
5,
RAG2, and germline 
 
k
 
 locus transcripts. However, these Ras–RAG pre-B cells also upregu-
lated surface markers characteristic of more mature B cell stages and populated peripheral lym-
phoid tissues, with an overall phenotype reminiscent of B lineage cells generated in a RAG-
deficient background as a result of expression of an Ig 
 
m
 
 HC together with a Bcl-2 transgene.
Taken together, these findings suggest that activated Ras signaling in pro-B cells induces devel-
opmental progression by activating both differentiation and survival signals.
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B
 
lymphocyte development proceeds through a series of
stages defined by the expression of surface markers and
by the status of Ig gene rearrangement (1). In this develop-
mental program, upon productive rearrangement and ex-
pression of Ig 
 
m
 
 heavy chain (HC)
 
1
 
 genes, B220
 
1
 
CD43
 
1
 
pro-B cells progress to B220
 
1
 
CD43
 
2
 
 pre-B cells. This
transition requires expression of the pre-B cell receptor
(pre-BCR) complex consisting of 
 
m
 
 HC associated with
the invariant surrogate light chain proteins 
 
l
 
5 and V
 
preB
 
,
most likely on the cell surface (2). Consistent with this no-
tion, targeted germline deletion of the 
 
m
 
 membrane exon
arrested murine B cell development at the pro-B cell stage
(3). Moreover, germline inactivation in mice of either the
recombinase-activating gene (RAG)1 or RAG2 genes,
which encode components of the V(D)J recombinase re-
quired for initiation of antigen receptor gene rearrange-
ment, again resulted in a block in B lymphocyte develop-
ment at the pro-B cell stage (4, 5). However, expression of
a rearranged 
 
m
 
 HC transgene in the RAG-deficient back-
ground partially rescued this developmental block in the B
lineage, leading to the generation of B220
 
1
 
CD43
 
2
 
 pre-B
cells and demonstrating that 
 
m
 
 chain expression was suffi-
cient to drive this developmental transition (6, 7).
Because the pre-BCR, like the mature BCR, has no
known intrinsic enzymatic functions, it must rely upon
associated proteins to provide a functional linkage with in-
tracellular signaling pathways. The mature and pre-BCR–
associated Ig
 
a
 
 and Ig
 
b
 
 contain immunoreceptor tyrosine-
based activation motifs (ITAMs), which are targets for
phosphorylation by tyrosine kinases (8); these proteins are
required for normal B cell development (9, 10). Further-
more, the importance of an ITAM-associated tyrosine ki-
nase activity during early B lymphopoiesis was demon-
strated in mice deficient in the syk tyrosine kinase, in
which an incomplete block in development was observed
at the B220
 
1
 
CD43
 
1
 
 pro-B cell stage (11, 12). Although
several downstream signaling pathways can be induced in B
cell lines (13), the identity of the targets downstream of the
 
1
 
Abbreviations used in this paper:
 
 BCR, B cell receptor; ES, embryonic
stem; DP, double positive (CD4
 
+
 
 CD8
 
+
 
); HC, immunoglobulin heavy
chain; RAG, recombinase-activating gene; RT, reverse transcriptase. 
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nonreceptor tyrosine kinases that are activated by the pre-
BCR complex
 
 
 
has remained unclear. In this context, the
Ras family of GTPases (14) represents an attractive candi-
date. In numerous vertebrate systems, Ras proteins have
been implicated in linking tyrosine kinase-mediated signal
transduction to downstream effectors (15). In the T cell
lineage, constitutive expression of activated Ras in a RAG-
deficient background has been shown to drive the expan-
sion and differentiation of double negative thymocytes to
the CD4
 
1
 
 CD8
 
1
 
 (double positive, or DP) stage (16).
Moreover, Ras-dependent signaling after cross-linking of
the mature BCR has also been observed in lymphocyte cell
lines (17, 18). We hypothesized that if activation of endog-
enous Ras represents a necessary event in pre-BCR signal-
ing, then introduction of constitutively activated Ras into
RAG-deficient pro-B cells could mimic signaling by the
pre-BCR and result in developmental progression.
 
Materials and Methods
 
DNA Constructs.
 
The plasmid pE
 
m
 
 was constructed through
ligation of a 1,042-bp fragment containing the Ig HC enhancer
(E
 
m
 
) linked to a variable region promoter (19) into the SmaI site
of Bluescript II SK. A BamHI/PstI fragment containing two ex-
ons of the human 
 
b
 
-globin gene was introduced at the KpnI site
of Bluescript II SK to provide splice sites and a polyadenylation
signal. pE
 
m
 
 was digested with SalI, treated with Klenow fragment
and alkaline phosphatase, and ligated to the c-Ha-ras V12 cDNA
(20) to complete pE
 
m
 
RasV12.
 
Embryonic Stem Cell Transfection and RAG2-deficient Chimera
Generation.
 
Cotransfection of RAG1
 
2/2
 
 (16) CCE embryonic
stem (ES) cells was carried out with 10 
 
m
 
g NotI-linearized
pE
 
m
 
RasV12 together with 1 
 
m
 
g linearized PGK-puro (a gift of
P.W. Laird, University of Southern California School of Medi-
cine, Los Angeles, CA). DNA was added to 10
 
7
 
 ES cells, and
transfection was via electroporation at 300 V, 70 
 
m
 
F twice. Cells
were selected in 0.5 
 
m
 
g/ml puromycin (Sigma Chemical Co.).
Drug-resistant ES colonies were picked and subcloned for injec-
tion into RAG2-deficient blastocysts as previously described (21).
 
Analysis of RAG2-deficient Chimeras.
 
RAG2-deficient chime-
ras were maintained in a pathogen-free environment, and were
analyzed at 4–6 wk of age. FACS
 
®
 
 analyses of bone marrow,
spleen, and lymph nodes were carried out as previously described
(22). Antibodies were purchased from PharMingen and were:
Cy-Chrome conjugated B220/CD45R (clone RA3-6B2); FITC-
conjugated CD21/35 (CR2/CR1) (7G6), CD22.2 (Cy34.1),
IgM (II/41), Ly 9.1 (30C7), B220/CD45R, and CD43 (S7); and
PE-conjugated CD43 (S7), CD2 (RM2-5), CD23 (B3B4), and
CD22.2. Analysis of stained samples was performed on a Becton
Dickinson FACSCalibur
 
®
 
, and sorting of B220
 
1
 
 Ly 9.1
 
1
 
 B lin-
eage cells was carried out on an Ortho Cytofluorograf II or Bec-
ton Dickinson FACScan
 
®
 
; dot plots were generated using Cell
Quest software (Becton Dickinson).
 
Western Blot Analysis.
 
After red blood cell lysis in ammonium
chloride, single-cell splenocyte or lymph node suspensions were
treated with RIPA lysis solution (0.15 mM NaCl, 0.05 mM Tris-
HCl, pH 7.2, 1% Triton X-100, 1% sodium deoxycholate, and
0.1% SDS) at 10
 
8
 
 cells per ml, and postnuclear supernatants were
prepared following standard procedures. Proteins were resolved
using SDS/10% PAGE (loading 2 
 
3 
 
10
 
6
 
 cell equivalents of lysate
per lane), transferred to Immobilon-P membranes (Millipore),
 
and probed with an anti-Ha-ras monoclonal antibody (clone
F235; Calbiochem), followed by a horseradish peroxidase–linked
F(ab
 
9
 
)
 
2
 
 sheep anti–mouse Ig (Boehringer Mannheim). For detec-
tion we used the ECL system (Amersham), and Ponceau-S stain-
ing was employed to verify equivalent protein loading.
 
Reverse Transcription PCR Analysis.
 
RNA was isolated from
10
 
6
 
 sorted B220
 
1
 
Ly 9.1
 
1
 
 cells derived from Ras–RAG1
 
2/2
 
 chi-
mera or wild-type lymph node and spleen, together with sorted
B220
 
1
 
CD43
 
2
 
IgM
 
2
 
 wild-type pre-B cells, and B220
 
1
 
CD43
 
1
 
RAG2-deficient pro-B cells using the TRIZOL reagent (GIBCO
BRL) and the manufacturer’s protocol. 2 
 
m
 
g of RNA was used
for first-strand cDNA synthesis using SuperScript II reverse tran-
scriptase (RT) (GIBCO BRL), following conditions recom-
mended by the manufacturer. 1% of each cDNA synthesis reac-
tion was used for PCR amplification, together with two serial
fivefold dilutions. 5- and 25-fold cDNA dilution samples were
mixed with cDNA derived from J1 ES cells to equalize template
amount in reactions amplifying lymphoid-specific 
 
l
 
5 and RAG2;
because Bcl-2 and Bcl-x
 
L
 
 were both expressed in ES cDNA (data
not shown), ES cell cDNA was not diluted into these reactions.
The ES cell cDNA dilution was determined through amplifica-
tion of 
 
b
 
-actin. 25 
 
m
 
l reactions contained: 1
 
3 
 
PCR buffer, 200
 
m
 
M dNTPs, 2 
 
m
 
M of both sense and antisense oligonucleotide
primers, and 1 U Taq polymerase (Qiagen). Primers for 
 
l
 
5,
RAG2, Bcl-2, and 
 
b
 
-actin were as previously described (23),
except that the 5
 
9
 
 
 
l
 
5 oligonucleotide primer was 5
 
9
 
 CT-
TGAGGGTCAATGAAGCTCAGA 3
 
9
 
. Primers for Bcl-x
 
L
 
 were
as previously described (24). All primers contained sequences
spanning at least two exons, allowing clear distinction between
RNA and genomic DNA signals. PCR amplification conditions
were as previously described (23). Expected sizes of amplified
products were: 
 
l
 
5, 337 bp; RAG2, 515 bp; Bcl-2, 315 bp, Bcl-x
 
L
 
,
557 bp; 
 
b
 
-actin, 623 bp. For analysis of germline 
 
k
 
 transcripts, a
primer 5
 
9
 
 of J
 
k
 
1 (5
 
9
 
CCACGCATGCTTGGAGAGGGGGTT3
 
9
 
)
and a 3
 
9
 
 primer within the coding sequence of J
 
k
 
2 were used
(25). RNA samples were treated with 5 U of RNase-free DNase
(Boehringer Mannheim) in 1
 
3
 
 RT buffer for 30 min at 37
 
8
 
C.
The DNase was inactivated at 75
 
8
 
C for 10 min, followed by re-
verse transcription as above. Since germline 
 
k
 
 transcripts could
not be distinguished from contaminating genomic DNA, samples
not treated with RT were subjected to PCR analysis. Conditions
for amplification were 95
 
8
 
C for 2 min, then 24 cycles at 95
 
8
 
C for
30 s, 60
 
8
 
C for 1 min, and 72
 
8
 
C for 1.5 min. PCR products were
resolved on 1.5% agarose gels, blotted onto Zetaprobe GT (Bio-
Rad), and probed with 
 
32
 
P-labeled cDNAs for 
 
l
 
5 (6), with
cloned PCR fragments for RAG2, 
 
b
 
-actin, Bcl-2, and Bcl-x
 
L
 
, or
with a HindIII fragment containing the germline J
 
k
 
 region (26).
 
Results
 
To direct expression of activated Ras to B lineage cells,
we used an expression construct containing a c-Ha-rasV12
cDNA and Ig HC regulatory sequences (Fig. 1 A). This ex-
pression construct was transfected into RAG1-deficient ES
cells (16), and the resulting ES clones were tested for their
ability to generate B lineage cells in the RAG2-deficient
blastocyst complementation assay (21). Flow cytometry
analysis of bone marrow cells from Ras–RAG chimeras re-
vealed low numbers of IgM
 
2
 
B220
 
1
 
CD43
 
2
 
 B lineage cells
(which are absent in RAG-deficient mice); however, these
cells were also found in the spleen and lymph nodes in
numbers approaching those of normal, Ig-positive B cells 
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in wild-type mice (Fig. 2 and data not shown). To verify
that B220
 
1 cells were derived from ES cells, the clonotypic
marker Ly 9.1 was used (data not shown). Furthermore,
expression of the Ha-ras protein in these chimeric mice
was confirmed by Western analysis of spleen and lymph
node cell lysates using an Ha-ras-specific monoclonal anti-
body (expression of endogenous Ras in lymphocytes is lim-
ited to N-ras and K-ras; reference 27) (Fig. 1 B). There-
fore, activated Ras expression results in the generation of B
lineage cell populations that substantially populate the peri-
pheral lymphoid tissues of RAG1–deficient mice.
To further delineate the stage of maturation of B lineage
cells in Ras–RAG mice, we assayed for expression of vari-
ous genes used to define stages of B cell differentiation.
RT-PCR assays demonstrated that populations of splenic
or lymph node Ras–RAG B lineage cells expressed
substantial levels of l5 and RAG2 transcripts, which are
normally transcribed in the pro-B and pre-B cells but gen-
erally are absent during later stages of development (23,
28). On the basis of semiquantitative RT-PCR analyses,
we determined that Ras–RAG cell populations expressed
l5 and RAG2 at levels comparable to those in purified
wild-type pre-B cells (Fig. 3). In normal mice, productive
rearrangement and expression of m HC genes in develop-
ing B cell progenitors leads to the transcriptional activation
and rearrangement of k light chain genes (29–33). To study
if signaling by activated Ras could mimic the induction of
k germline transcription normally induced by expression of
HC in pro-B cells, we determined the levels of germline k
transcripts in Ras–RAG B lineage cells. We observed that
such transcripts were present in Ras–RAG B lineage cells
at levels similar to those in wild-type pre-B cells (Fig. 4).
These results suggest that activated Ras signaling in RAG-
deficient B lineage cells promotes transcriptional activation
of the k light chain gene locus.
Given the large number of peripheral B lineage cells in
Ras–RAG mice, we further assayed for staining of more
mature B cell surface markers. On the basis of these assays,
we also found that the Ras–RAG B lineage cells in both
the bone marrow and periphery expressed surface antigens
usually associated with later stages of B cell development,
such as the low affinity IgE Fc receptor CD23 (34), the
BCR coreceptor CD22 (35), and complement receptor
CD21/CD35 (36) (Fig. 2 and data not shown). Thus, our
data suggest that expression of activated Ras results in the
development of RAG-deficient B lineage cells that retain
major properties of pre-B lymphocytes while also express-
ing cell surface markers usually found only in mature B cell
stages. These Ras–RAG B lineage cells are distinct from
those generated in the RAG-deficient background via ex-
pression of an Ig m HC transgene, which only promotes dif-
ferentiation to cells that show pre-B cell characteristics and
remain primarily in the bone marrow (6, 7), but are similar
in patterns of gene expression and tissue distribution to
those observed in m HC/Bcl-2 double transgenic, RAG-
deficient mice (22, 37).
Figure 1. Activated c-Ha-Ras
expression vector and Western
blot analysis of c-Ha-Ras expres-
sion.  (A) Diagram of the
pEmRasV12 expression vector.
Em, Ig HC enhancer; VH, HC
variable region promoter; Ras,
c-Ha-ras V12 cDNA; b-globin,
b-globin exons 2 and 3 with
polyadenylation signal. (B)
Western blot analysis of total
spleen or lymph node lysates
from a Ras–RAG12/2, RAG2-deficient chimera and RAG2-deficient
mouse, probed with a monoclonal antibody against Ha-ras. The position
of p21 Ha-ras is indicated by the arrow. Ponceau-S staining was em-
ployed to verify equivalent loading of protein. Lane 1, Ras–RAG12/2 to-
tal lymph node; lane 2, Ras–RAG12/2 total spleen; lane 3, RAG22/2 to-
tal spleen.
Figure 2. Surface phenotype of Ras–RAG B lineage cells. Lymphocytes
isolated from lymph node of Ras–RAG12/2, RAG2-deficient chimera,
RAG22/2, and wild-type (129 Sv/Ev) mice were subjected to FACS® anal-
yses. Depicted are log-scale dot plots of B220 versus CD43, IgM, CD23,
and CD21/CD35. The plots reflect 20,000 collected events, with dead cells
excluded by forward and side scatter. Similar results were found in the
spleen. Results shown are representative of those obtained in the analysis of
six chimeric mice derived from two independent transfected ES clones.
The number of B2201Ly9.11 cells in these RAG2-deficient chimeras
ranged from 5 3 105 to 1.6 3 107 in lymph node and 2 3 106 to 7 3 106
in spleen. Chimeric animals analyzed for evidence of B cell developmental
progression showed no gross evidence of malignancy. Older chimeric mice
do tend to develop B lineage lymphomas, but such transformed cells are
significantly larger in cell size and have markedly altered surface antigen
staining characteristics (data not shown). Ras-Rag, activated Ras-comple-
mented-RAG1–/–, RAG2-deficient chimera; Rag, RAG22/2 mouse.126 Activated Ras Signaling in RAG-deficient pro-B Lymphocytes
The similarity of the Ras–RAG phenotype to that pro-
moted by m HC plus Bcl-2 transgenes suggested to us that
activated Ras may signal both differentiative and cell sur-
vival processes. During normal B cell development, the anti-
apoptotic gene Bcl-2 is expressed at the pro-B stage, but is
downregulated in pre-B cells and later upregulated in ma-
ture B lymphocytes (23, 38). In contrast, the cell survival
gene Bcl-xL displays a reciprocal pattern of expression, with
high levels in pre-B cells that are downregulated in mature
B cells (39). To assay for Bcl-2 and Bcl-xL expression in
sorted Ras–RAG peripheral B lineage cells, we used RT-
PCR analysis and determined that the expression levels of
Bcl-2 and Bcl-xL in Ras–RAG B cells were more compa-
rable with those in wild-type mature B cells with substan-
tial levels of Bcl-2 expression (Fig. 5).
Discussion
Several studies have implicated Ras as an intermediate in
signal transduction downstream of the BCR (17, 18). Our
studies of Ras–RAG mice demonstrate that activated Ras
can induce differentiation of pro-B cells in the absence of m
HC. B lineage cells that develop in Ras–RAG mice ac-
quired characteristics shared with normal pre-B cells, in-
cluding expression of RAG and l5, and the induction of
germline k light chain locus transcripts. However, these
cells also expressed surface markers characteristic of more
mature stages of B lymphopoiesis. Thus, we believe it is
most likely that Ras–RAG B cells have progressed in their
differentiation beyond the pre-B cell stage, at least to the
pre-B–B cell junction. It also remains possible, given their
peripheral location, that Ras–RAG B cells may be devel-
opmentally similar to the recently described subset of ger-
minal center B cells that reinitiate light chain gene rear-
rangement as a result of antigenic challenge (40–42).
Although such cells, unlike Ras–RAG B cells, lack CD23
expression (43), both cell types demonstrate the concurrent
expression of l5 and RAG genes with mature B cell sur-
face markers. The accumulation of the Ras–RAG B lin-
eage cells in the periphery could be due to several potential
effects of activated Ras expression, including acquisition of
surface markers necessary for transit from the bone marrow
or prolonged survival allowing exit from the marrow and
accumulation in the periphery.
Previous work has demonstrated that the introduction of
a rearranged m transgene into RAG-deficient pro-B cells
induced their differentiation to pre-B cells (6, 7). Although
such cells remained predominantly within the bone mar-
row and did not express surface markers characteristic of
more mature B cells, the expression of a Bcl-2 transgene in
the B lineage of m-RAG mice resulted in the appearance of
cells in the marrow and periphery with a phenotype that
resembles B lineage cells found in Ras–RAG mice (22, 37).
These findings suggested that survival signals provided by
Bcl-2 may advance B lymphopoiesis beyond the stage
achieved by m HC alone. In this regard, we found that
Ras–RAG cells expressed significantly higher levels of en-
dogenous Bcl-2 than normal pre-B cells; in fact, the ob-
served Bcl-2 expression levels approached those in mature
B cells. At present, we do not know whether this upregula-
tion of Bcl-2 expression in Ras–RAG cells is directly in-
Figure 3. Analysis of l5 and RAG expression. RNA isolated from
Ras–RAG12/2 (Ras-Rag), wild-type mature B (WT B), and wild-type
pre-B (WT Pre-B) lymphocytes purified from lymph node and spleen
was reverse transcribed, and first-strand cDNA was subjected to PCR
analysis using l5, RAG2, and b-actin primer pairs (see Materials and
Methods). For each B lineage cell type, serial fivefold dilutions are shown.
ES cell cDNA was added to the 5- and 25-fold dilutions of each B lineage
cDNA sample to equalize template quantity. Single lanes containing no
cDNA (H2O) or ES cDNA alone are shown for each primer pair.
Figure 4. k light chain locus germline transcripts are upregulated in
Ras–RAG B lineage cells.  RNAs from sorted B2201 Ly 9.11Ras–
RAG12/2 (Ras-Rag) B lineage cells, from B2201 CD432IgM2 wild-type
pre-B cells (WT Pre-B), and from B2201CD431 RAG2-deficient pro-B
cells (Rag Pro-B) were subjected to RT-PCR analysis for detection of
germline k transcripts. Serial fivefold dilutions are shown, and ES cell
cDNA was diluted into 5- and 25-fold dilutions. Samples with (1) and
without (–) reverse transcriptase are indicated.
Figure 5. Analysis of Bcl-2 and Bcl-xL expression. RNAs from sorted
Ras–RAG12/2 (Ras-Rag), mature wild-type B (WT B), and wild-type
pre-B (WT Pre-B) lymphocytes were subjected to RT-PCR analysis, using
b-actin expression as a standard. Serial fivefold dilutions are shown for each
B lineage cell type.127 Shaw et al.
duced by activated Ras, or, alternatively, occurs as a result
of developmental progression to a more mature stage. Nev-
ertheless, the phenotypic similarities between m HC/Bcl-
2/RAG and Ras–RAG B cells suggest that introduction of
activated Ras may induce and/or enable both differentia-
tion and survival signals in RAG-deficient and, presum-
ably, normal progenitor B lineage cells.
Our finding that B cells in Ras–RAG mice develop to a
stage beyond that of B cells in m-RAG mice indicates that
signaling events triggered by constitutively activated Ras
may surpass or differ from those initiated upon HC-medi-
ated activation of endogenous Ras. In this context, in other
experimental systems the effects of activated Ras on cul-
tured cells varied depending on the level and duration of
Ras expression (44). It is also possible that the expression of
activated Ras in B lineage cells mimics signaling from other
surface receptors, in addition to the pre-BCR, which nor-
mally trigger endogenous Ras. Numerous Ras effector
pathways have been identified to date, including a well-
characterized mitogen-activated protein kinase cascade and
a growing number of stress-activated protein kinase cas-
cades (45). Ras has also been shown to induce phosphati-
dylinositol-3 kinase (46, 47), as well as the Rho family of
GTPases which regulate the actin cytoskeleton (48). It re-
mains to be established which of these (or other) Ras-effec-
tor pathways are involved in mediating the developmental
progression of pro-B cells. Selective engagement of Ras ef-
fectors using activated mutant alleles may facilitate further
elucidation of these issues.
Recent data demonstrate that Ras signaling is used dur-
ing several stages of B and T lymphocyte development. For
example, a dominant negative Ras transgene was shown to
cause an incomplete block in B cell development at the
earliest known B cell precursor stage before B2201CD431
pro-B cells (49). In T lineage cells, several studies with
dominant negative alleles implicated the Ras/Raf/Mito-
gen-activated protein kinase pathway in the development
of CD41CD81 (DP) thymocytes and mature T cells (50–
52). Notably, a complete reconstitution of DP thymocytes
was induced by activated Ras in RAG-deficient mice;
however, in these mice no developmental progression be-
yond the DP stage was observed, and no T cells were de-
tected in the peripheral lymphoid organs (16). These results
suggested that additional signals are required for the T cell
positive selection process that normally results from signal-
ing events accompanying ligation of the T cell receptor
with self-MHC ligands of specific avidity (53). Such a re-
quirement for additional signaling events, independent of
Ras, in the development of T cells beyond the DP stage
suggests that an important distinction may exist in the sig-
nals required to effect further development of precursor B
versus precursor T lineage cells.
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